Acrolein-mediated mechanisms of neuronal death

Journal of Neuroscience Research

Volumn 84, Issue 1, 2006, Pages 209-218

  Liu Snyder, Peishan ^a   McNally, Helen ^a   Shi, Riyi ^a,b   Borgens, Richard Ben ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Acrolein; Endogenous toxin; Lipid peroxidation; Neurotrauma; Secondary injury

Indexed keywords

ACROLEIN; CALPAIN; CASPASE 3;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL DEATH; CELL POPULATION; CELL STRAIN; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DNA DETERMINATION; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; MICROSCOPY; MITOCHONDRION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; SPINAL GANGLION; SYMPATHETIC GANGLION;

ACROLEIN; ANIMALS; CALPAIN; CASPASE 3; CASPASES; CELL DEATH; CELL DIFFERENTIATION; CYTOKINES; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ATOMIC FORCE; MICROTUBULES; MITOCHONDRIA; NERVE GROWTH FACTOR; NEURONS; PC12 CELLS; RATS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 33745790878     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20863     Document Type: Article

References (21)

1. Borgens RB. 2003. Restoring function to the injured human spinal cord. In: Advances in anatomy, embryology and cell biology [monograph]. Heidelberg: Springer-Verlag. 17 p.
2. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, Marshall LF, Perot PL Jr, Piepmeier J, Sonntag VKH, Wagner FC, Wilberger JE, Winn HR. 1990. A randomized controlled trial of methylprednisilone or naloxone in the treatment of acute spinal cord injury. N Engl J Med 322:1405-1411.
3. Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon JC, Marshall LF. 1992. Methylprednisilone or naloxone after acute spinal cord injury:1 year follow up data: results of the second national spinal cord injury study. J Neurosurg 76:23-31.
4. Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W. 1997. Administration of methyoprednisilone for 24 or 48 hr or tirilazad mesylate for 48hr in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. Acute spinal cord injury study. JAMA 277:1597-1604.
5. Bracken MB, Shepard MJ, Hellenbrand K. 1985. Methylprednisolone and neurological function one year after spinal cord injury. J Neurosurg 63:704-713.
6. Bronk SF, Gores GJ. 1993. pH-dependent nonlysosomal proteolysis contributes to lethal anoxic injury of rat hepatocytes. Am J Physiol 264:G744-G751.
7. Demopoulos HB, Flamm ES, Seligman ML, Pietronigro DD, Tomasula J, DeCrescito V. 1982. Further studies on free radical pathology in the major central system disorders: effects of very high doses of methylprednisilone on the functional outcome, morphology, and chemistry of experimental spinal cord injury. Can J Physiol Pharmacol 60:1415-1424.
8. Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128.
9. Ghilarducci DP, Tjeerdema RS. 1995. Fate and effects of acrolein. Rev Environ Contam Toxicol 144:95-146.
10. Hall ED. 1993. The effects of glucocorticoid and nonglucocorticoid steroids on acute neuronal degeneration. Adv Neurol 59:241-248.
11. Higgin D, Banker G. 1998. Primary dissociated cell cultures. In: Higgin D, Banker G, editors. Culturing nerve cells. Cambridge, MA: MIT Press. p 37-78.
12. Luo J, Uchida K, Shi R. 2005. Accumulation of acrolein-protein adducts after traumatic spinal cord injury. Neurochem Res 30:291-295.
13. McNally H, Borgens R. 2004. Three-dimensional imaging of living and dying neurons with atomic force microscopy. J Neurocytol 33:251-258.
14. Nardini M, Finkelstein EI, Reddy S, Valacchi G, Traber M, Cross CE, van der Vliet A. 2002. Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 170:173-185.
15. Peasley M, Shi R. 2003. Ischemic insult exacerbates acrolein-induced conduction loss and axonal membrane disruption in guinea pig spinal cord white matter. J Neurol Sci 216:23-32.
16. Pointillart V, Petitjean ME, Wiart L, Vital JM, Lassie P, Thicoipe M, Dabadie P. 2000. Pharmacological therapy of spinal cord injury in the acute phase. Spinal Cord 38:71-76.
17. Sapolsky RM, Pulsinelli WA. 1985. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 229:1397-1400.
18. Satoh K, Yamada S, Koike Y, Igarashi Y, Toyokuni S, Kumano T, Takahata T, Hayakari M, Tsuchida S, Uchida K. 1999. A 1-hour enzyme-linked immunosorbent assay for quantitation of acrolein- and hydroxynonenal-modified proteins by epitope-bound casein matrix method. Anal Biochem 270:323-328.
19. Shi R, Luo J, Peasley M. 2002. Acrolein inflicts axonal membrane disruption and conduction loss in isolated guinea-pig spinal cord. Neuroscience 115:337-340.
20. Short DJ, Massry WS, Jones PW. 2000. High-dose Methylprednisilone in the management of acute spinal cord injury - a systematic review from a clinical perspective. Spinal Cord 38:273-286.
21. Smith C. 1998. Culturing from chicken peripheral ganglia. In: Higgin D, Banker G, editors. Culturing nerve cells. Cambridge. MA: MIT Press, p 261-288.